The current gold-standard treatment of CD is based on shifting the excessive immune response and decreasing inflammation in the colon by targeting various proteins in the inflammatory cascades such as tumor necrosis factor (TNF—α), p40 subunit of interleukin 12/23 (IL 12/23) and integrin a4B7 to name only a few [3]. Here, TNF is linked to Cowden disease.